Page last updated: 2024-11-11

indole-3-acetaldoxime

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

(E)-indol-3-ylacetaldehyde oxime : An indol-3-ylacetaldehyde oxime in which the oxime moiety has E configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5371769
CHEBI ID17545
SCHEMBL ID578643
MeSH IDM0440873

Synonyms (17)

Synonym
CHEBI:17545
(e)-indol-3-ylacetaldehyde oxime
n-[(1e)-2-(1h-indol-3-yl)ethylidene]hydroxylamine
2776-06-9
indole-3-acetaldehyde oxime
indole-3-acetaldoxime ,
C02937
(e)-indol-3-ylacetaldoxime
(e)-(1h-indol-3-yl)acetaldehyde oxime
(e)-(indol-3-yl)acetaldehyde oxime
ccris 5809
(ne)-n-[2-(1h-indol-3-yl)ethylidene]hydroxylamine
SCHEMBL578643
(1e)-1h-indol-3-ylacetaldehyde oxime
(1h-indol-3-yl)acetaldoxime
Q27121272
2-(1H-INDOL-3-YL)ACETALDEHYDE OXIME
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
indol-3-ylacetaldehyde oximeAn aldoxime resulting from the formal condensation of the aldehyde moiety of indol-3-ylacetaldehyde with hydroxylamine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (6)

PathwayProteinsCompounds
indole-3-acetate biosynthesis II820
Glucosinolate biosynthesis (from aromatic amino acid)021
Camalexin Biosynthesis821
camalexin biosynthesis318
4-hydroxyindole-3-carbonyl nitrile biosynthesis413
glucosinolate biosynthesis from tryptophan1229
camalexin biosynthesis517
indole-3-acetate biosynthesis II621
glucosinolate biosynthesis from tryptophan532
IAA biosynthesis I025

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (45.45)29.6817
2010's9 (40.91)24.3611
2020's3 (13.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.97 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (13.04%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (86.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]